These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 26285072)

  • 1. Oxidative stress in β-thalassaemia and sickle cell disease.
    Voskou S; Aslan M; Fanis P; Phylactides M; Kleanthous M
    Redox Biol; 2015 Dec; 6():226-239. PubMed ID: 26285072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.
    Ataga KI; Cappellini MD; Rachmilewitz EA
    Br J Haematol; 2007 Oct; 139(1):3-13. PubMed ID: 17854302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.
    Ghoti H; Goitein O; Koren A; Levin C; Kushnir T; Rachmilewitz E; Konen E
    Eur J Haematol; 2010 Jan; 84(1):59-63. PubMed ID: 19793250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocytes anion transport and oxidative change in beta-thalassaemias.
    Maria C; Leonardo R; Pietro R; Mario V; Isabella V; Diana T
    Cell Biol Int; 2010 May; 34(6):655-62. PubMed ID: 20450494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet and not erythrocyte microparticles are procoagulant in transfused thalassaemia major patients.
    Agouti I; Cointe S; Robert S; Judicone C; Loundou A; Driss F; Brisson A; Steschenko D; Rose C; Pondarré C; Bernit E; Badens C; Dignat-George F; Lacroix R; Thuret I
    Br J Haematol; 2015 Nov; 171(4):615-24. PubMed ID: 26205481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-transferrin-bound iron: a promising biomarker in iron overload disorders].
    Maas RP; Voets PJ; de Swart L; Swinkels DW
    Ned Tijdschr Geneeskd; 2013; 157(49):A6258. PubMed ID: 24299624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights provided by a comparison of impaired deformability with erythrocyte oxidative stress for sickle cell disease.
    Barodka VM; Nagababu E; Mohanty JG; Nyhan D; Berkowitz DE; Rifkind JM; Strouse JJ
    Blood Cells Mol Dis; 2014 Apr; 52(4):230-5. PubMed ID: 24246527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy.
    Westerman M; Pizzey A; Hirschman J; Cerino M; Weil-Weiner Y; Ramotar P; Eze A; Lawrie A; Purdy G; Mackie I; Porter J
    Br J Haematol; 2008 Jul; 142(1):126-35. PubMed ID: 18422994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias.
    Ho PJ; Tay L; Lindeman R; Catley L; Bowden DK
    Intern Med J; 2011 Jul; 41(7):516-24. PubMed ID: 21615659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.
    Adeyemo T; Ojewunmi O; Oyetunji A
    Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Molecule Studies of the Diffusion of Band 3 in Sickle Cell Erythrocytes.
    Spector J; Kodippili GC; Ritchie K; Low PS
    PLoS One; 2016; 11(9):e0162514. PubMed ID: 27598991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.
    Walter PB; Fung EB; Killilea DW; Jiang Q; Hudes M; Madden J; Porter J; Evans P; Vichinsky E; Harmatz P
    Br J Haematol; 2006 Oct; 135(2):254-63. PubMed ID: 17010049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle-cell disease and the heart: review of the current literature.
    Voskaridou E; Christoulas D; Terpos E
    Br J Haematol; 2012 Jun; 157(6):664-73. PubMed ID: 22530942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac iron overload in sickle-cell disease.
    Meloni A; Puliyel M; Pepe A; Berdoukas V; Coates TD; Wood JC
    Am J Hematol; 2014 Jul; 89(7):678-83. PubMed ID: 24664847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labile iron pool as a parameter to monitor iron overload and oxidative stress status in β-thalassemic erythrocytes.
    Chutvanichkul B; Vattanaviboon P; Mas-Oodi S; U-Pratya Y; Wanachiwanawin W
    Cytometry B Clin Cytom; 2018 Jul; 94(4):631-636. PubMed ID: 29486524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress status, clinical outcome, and β-globin gene cluster haplotypes in pediatric patients with sickle cell disease.
    Rusanova I; Escames G; Cossio G; de Borace RG; Moreno B; Chahboune M; López LC; Díez T; Acuña-Castroviejo D
    Eur J Haematol; 2010 Dec; 85(6):529-37. PubMed ID: 20846340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in sickle cell disease: an overview of erythrocyte redox metabolism and current antioxidant therapeutic strategies.
    Silva DGH; Belini Junior E; de Almeida EA; Bonini-Domingos CR
    Free Radic Biol Med; 2013 Dec; 65():1101-1109. PubMed ID: 24002011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.